Tailor-made solutions for your requirements in pharmaceutical development
Our commitment and experience in pharmaceutical development make us your ideal partner
Recent News
Kester Capital backs management buy-out of Rephine
Rephine is delighted to announce the purchase of the business via a management buy-out, by a team comprising the existing senior managers together with a ...
Read More Getting Ready for the Clinical Trial Regulation
It’s been a difficult year for many biopharma companies and perhaps even more so for clinical research organisations, with Covid-19 forcing the postponement or even ...
Read More Medical Devices Back in the Spotlight
The global disruption caused by the pandemic meant regulatory plans for 2020 needed to be delayed to give the life sciences industry and authorities breathing ...
Read More Data protection to take centre stage in 2021
In early December, the EMA announced that it had been hit by a cyber-attack and that documents related to the Pfizer-BioNTech Covid-19 vaccines had been ...
Read More